Axio Biosolutions: Financial Breakdown
Decoding financial health metrics of Axio Biosolutions
Total Revenue₹24.0 Cr+31%Prev. FY
Total Expenses₹29.6 Cr+7%Prev. FY
Profit After Tax₹-5.7 Cr+39%Prev. FY
Total Assets₹16.4 Cr+-36%Prev. FY
Net Profit Margin-23.6%54%Prev. FY
FAQs on Financials of Axio Biosolutions
No. In FY23, Axio Biosolutions reported a net loss of ₹5.7 Cr+, so it was not profitable.
Axio Biosolutions's revenue grew 31.9% year-on-year, from ₹18.2 Cr+ in FY22 to ₹24.0 Cr+ in FY23.
In FY23, Axio Biosolutions posted revenue of ₹24.0 Cr+ (up 31.9% YoY) and a net loss of ₹5.7 Cr+. Explore the full financials of Axio Biosolutions here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links